V
62
-2
CMA
52
-3
TDC
59
-3
SE
88
5
VLO
43
-2
CHD
42
2
KSS
36
-5
DTE
54
5
CVX
28
2
AEP
59
3
WMB
59
4
FDX
46
2
O
39
4
SYY
44
-3
WEC
65
2
MET
61
-2
FCX
42
6
CNP
52
-10
DVA
46
-3
EXPE
61
2
V
62
-2
CMA
52
-3
TDC
59
-3
SE
88
5
VLO
43
-2
CHD
42
2
KSS
36
-5
DTE
54
5
CVX
28
2
AEP
59
3
WMB
59
4
FDX
46
2
O
39
4
SYY
44
-3
WEC
65
2
MET
61
-2
FCX
42
6
CNP
52
-10
DVA
46
-3
EXPE
61
2
Financhill
Back

Praxis Precision Medicines Stock Predictions

This $60K Foldable Home Is Shaking Up Real Estate

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Sell
33

PRAX
Praxis Precision Medicines

Last Price:
$36.14
Seasonality Move:
-3.67%

7 Day Trial

ALL ACCESS PASS

$ 7

Could BOXABL Be the Tesla of Housing?

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.

Praxis Precision Medicines Stock Forecast

  • Over the next 52 weeks, Praxis Precision Medicines has on average historically risen by 9.8% based on the past 4 years of stock performance.
  • Praxis Precision Medicines has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
  • Is Praxis Precision Medicines Stock Undervalued?
    The current Praxis Precision Medicines [PRAX] share price is $37.55. The Score for PRAX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • PRAX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Praxis Precision Medicines Stock Go Up Next Year?

  • Over the next 52 weeks, Praxis Precision Medicines has on average historically risen by 9.8% based on the past 4 years of stock performance.

Praxis Precision Medicines Stock Rating

Sell
33
Praxis Precision Medicines (PRAX) is a Sell

Is Praxis Precision Medicines overpriced?

  • Praxis Precision Medicines has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%

Praxis Precision Medicines Stock Price History

Is PRAX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRAX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
praxismedicines.com

52-Week Data

52-Week High:
91.83
52-Week Low:
26.70

Prediction Charts

Market Cap:
764.9M
Price in USD:
37.55
Volume:
172.9K
Beta:
2.67

Technical Analysis

SMA50:
36.03
SMA100:
52.47
SMA200:
59.17
52-Wk Change:
-12.08%

Stock Predictions

  • Is Praxis Precision Medicines stock public?
    Yes, Praxis Precision Medicines is a publicly traded company.
  • What is the Praxis Precision Medicines stock quote today?
    The Praxis Precision Medicines stock price is 37.55 USD today.
  • How to buy Praxis Precision Medicines stock online?
    You can buy Praxis Precision Medicines shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-6 38.13 35.17 38.42 34.89
May-7 36.09 38.09 38.63 35.18
May-8 38.18 38.06 38.97 36.63
May-9 38.05 38.35 39.40 37.97
May-12 39.36 38.42 40.01 37.91
May-13 38.36 37.32 38.36 36.73
May-14 37.64 37.10 37.96 35.41
May-15 37.32 37.20 37.51 35.87
May-16 37.26 37.02 37.71 36.88
May-19 36.43 37.35 37.88 35.65
May-20 37.15 39.70 39.70 36.66
May-21 39.21 37.68 39.74 37.12
May-22 37.27 38.31 38.86 36.85
May-23 37.36 37.55 37.85 36.64

Praxis Precision Medicines Earnings

Praxis Precision Medicines Earnings Report: Per Share Praxis Precision Medicines Earnings Q1 Q2 Q3 and Q4 last year and next year.

Praxis Precision Medicines Forecast Revenue Growth

Praxis Precision Medicines Stock Analysis: Historical quarterly revenues per share for Praxis Precision Medicines and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $1.31 per share, a decrease next quarter of $0.24 per share, a decrease this year of $2.91 per share, and an increase next year of $0.92 per share.

* Praxis Precision Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.